Prevalence of Age-Related Macular Degeneration in Europe

2017474 citationsReviewhybrid Open Access

Authors

Johanna M. Colijn · Erasmus MC

Gabriëlle H.S. Buitendijk · Erasmus MC

Elena Prokofyeva · Institut Scientifique de Santé Publique

Dalila Alves · Association for Innovation and Biomedical Research on Light and Image

Maria L. Cachulo · Association for Innovation and Biomedical Research on Light and Image

Anthony P. Khawaja · Moorfields Eye Hospital NHS Foundation Trust

Audrey Cougnard‐Grégoire

Abstract

We observed a decreasing prevalence of AMD and an improvement in visual acuity in CNV occuring over the past 2 decades in Europe. Healthier lifestyles and implementation of anti-vascular endothelial growth factor treatment are the most likely explanations. Nevertheless, the numbers of affected subjects will increase considerably in the next 2 decades. AMD continues to remain a significant public health problem among Europeans.

Topics & Keywords

Retinal Diseases and Treatments Retinal Imaging and Analysis Glaucoma and retinal disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Ophthalmology

Volume 124, Issue 12, pp. 1753-1763

DOI: 10.1016/j.ophtha.2017.05.035

Field-Weighted Citation Impact: 34.51

Command Palette